We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.7M
AUM Growth
+$817K
(+0.96%)
Cap. Flow
+$429K
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
19.06%
Holding
557
New
35
Increased
169
Reduced
196
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.51M |
| 2 |
VF Corp
VFC
|
+$1.31M |
| 3 |
Marathon Petroleum
MPC
|
+$819K |
| 4 |
Eversource Energy
ES
|
+$586K |
| 5 |
Westwood Holdings Group
WHG
|
+$470K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$1.29M |
| 2 |
JNS
Janus Capital Group Inc
JNS
|
+$1.08M |
| 3 |
McDonald's
MCD
|
+$1.02M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$517K |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$516K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.97% |
| 2 | Technology | 13.46% |
| 3 | Industrials | 12.4% |
| 4 | Healthcare | 12.18% |
| 5 | Consumer Discretionary | 11.56% |
Similar funds
EW
AFG
ANBOT
P
FCM
SPW
SHF
NS
Weaver C. Barksdale & Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Weaver C. Barksdale & Associates held 557 positions worth $85.7M, up 0.96% from $84.9M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Weaver C. Barksdale & Associates's Q2 2017 filing shows 35 new, 169 increased, 196 reduced and 43 closed positions. Its largest new stake was Texas Instruments: 18,827 shares worth $1.45M. The largest sale was Novartis, an estimated $1.29M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Weaver C. Barksdale & Associates's largest Q2 2017 buy was Texas Instruments: 18,827 shares worth $1.45M.
- Weaver C. Barksdale & Associates added most to Marathon Petroleum in Q2 2017, an estimated $819K increase.
- Weaver C. Barksdale & Associates's biggest Q2 2017 reduction was Alliance Resource Partners, cutting an estimated $337K.
- Weaver C. Barksdale & Associates fully exited Novartis in Q2 2017, selling an estimated $1.29M.
- Weaver C. Barksdale & Associates's ten largest holdings make up 19% of its $85.7M portfolio in Q2 2017.
- Weaver C. Barksdale & Associates opened 35 new positions and closed 43 in Q2 2017.
- Weaver C. Barksdale & Associates's portfolio value rose 0.96% quarter-over-quarter to $85.7M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2017, filed 13 Jul 2017.